Nacka, Sweden, April 24, 2024: The Board of Atlas Copco AB has decided to use the mandates granted by the Annual General Meeting for the repurchase and sale of shares at one or more occasions until the next Annual General Meeting.

The mandates cover:

1) The acquisition of not more than 10,000,000 series A shares related to personnel option plan for 2024, whereof a maximum of 8,000,000 may be transferred to option holders under the performance based personnel option plan 2024.
2) The acquisition of not more than 60,000 series A shares, later to be sold on the market in connection with payment to Board members who have opted to receive synthetic shares as part of their remuneration.
3) The sale of not more than 60,000 series A shares to cover costs, primarily social charges, related to previously issued synthetic shares to Board members.
4) The sale of a maximum 26,000,000 series A shares currently held by the company, for the purpose of covering costs of fulfilling obligations related to the performance-based personnel option plans 2017, 2018, 2019, 2020 and 2021.

Repurchases and sales are subject to market conditions, regulatory restrictions, and the capital structure at any given time.

The number of issued shares is presently 4,918,452,416 whereof 3,357,576,384 series A shares and 1,560,876,032 series B shares.

For more information please contact:

Christina Malmberg Hägerstrand, Media Relations Manager
+46 72 855 93 29
media@atlascopco.com

About Atlas Copco Group:

Atlas Copco Group enables technology that transforms the future. We innovate to develop products, services and solutions that are key to our customers' success. Our four business areas offer compressed air and vacuum solutions, energy solutions, dewatering and industrial pumps, industrial power tools and assembly and machine vision solutions. In 2023, the Group had revenues of BSEK 173, and at year end about 53 000 employees. www.atlascopcogroup.com

https://news.cision.com/atlas-copco/r/atlas-copco-to-utilize-mandates-to-repurchase-and-sell-shares,c3967381

https://mb.cision.com/Main/90/3967381/2758197.pdf

(c) 2024 Cision. All rights reserved., source Press Releases - English